Assignee
OREXIGEN THERAPEUTICS INC
US·14 granted patents·27 pending applications·272 citations·filing 2004–2017
Top patents by PatentIndex Score
41 records- 0196US9125868B2Methods for administering weight loss medicationsOREXIGEN THERAPEUTICS INC·Filed 2014·Granted Sep 8, 2015·40 cites·17 claims
- 0295US7462626B2Compositions for affecting weight lossOREXIGEN THERAPEUTICS INC·Filed 2006·Granted Dec 9, 2008·42 cites·49 claims
- 0394US9119850B2Compositions and methods for weight loss in at risk patient populationsOREXIGEN THERAPEUTICS INC·Filed 2015·Granted Sep 1, 2015·15 cites·3 claims
- 0494US9107837B2Sustained release formulation of naltrexoneOREXIGEN THERAPEUTICS INC·Filed 2014·Granted Aug 18, 2015·13 cites·17 claims
- 0594US7375111B2Compositions for affecting weight lossOREXIGEN THERAPEUTICS INC·Filed 2004·Granted May 20, 2008·60 cites·8 claims
- 0693US8969371B1Compositions and methods for weight loss in at risk patient populationsOREXIGEN THERAPEUTICS INC·Filed 2014·Granted Mar 3, 2015·18 cites·6 claims
- 0792US7429580B2Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight lossOREXIGEN THERAPEUTICS INC·Filed 2005·Granted Sep 30, 2008·33 cites·26 claims
- 0891US9801875B2Compositions and methods for weight loss in at risk patient populationsOREXIGEN THERAPEUTICS INC·Filed 2015·Granted Oct 31, 2017·8 cites·20 claims
- 0988US11324741B2Methods for treating visceral fat conditionsOREXIGEN THERAPEUTICS INC·Filed 2017·Granted May 10, 2022·2 cites·18 claims
- 1088US9457005B2Compositions and methods for increasing insulin sensitivityOREXIGEN THERAPEUTICS INC·Filed 2014·Granted Oct 4, 2016·9 cites·17 claims
- 1187US9633575B2Methods of treating overweight and obesityOREXIGEN THERAPEUTICS INC·Filed 2013·Granted Apr 25, 2017·9 cites·19 claims
- 1286US7425571B2Method for treating obesityOREXIGEN THERAPEUTICS INC·Filed 2004·Granted Sep 16, 2008·19 cites·28 claims
- 1385US10322121B2Methods of providing weight loss therapy in patients with major depressionOREXIGEN THERAPEUTICS INC·Filed 2016·Granted Jun 18, 2019·4 cites·17 claims
- 1470US2014309252A1Compositions and methods for reducing food cravingsOREXIGEN THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1566US2011144145A1Methods for treating visceral fat conditionsOREXIGEN THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1665US10238647B2Compositions for affecting weight lossOREXIGEN THERAPEUTICS INC·Filed 2016·Granted Mar 26, 2019·0 cites·17 claims
- 1765US2015164806A1Layered pharmaceutical formulationsOREXIGEN THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1865US2008110792A1Methods for administering weight loss medicationsOREXIGEN THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1965US2007275970A1Compositions for affecting weight lossOREXIGEN THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 2065US2007270450A1Compositions for affecting weight lossOREXIGEN THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 2165US2017014404A1Sustained release formulation of naltrexoneOREXIGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2264US2009076108A1Method for treating obesityOREXIGEN THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 2363US2015119417A1Methods for treating visceral fat conditionsOREXIGEN THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2463US2016158225A1Sustained release formulation of naltrexoneOREXIGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2562US2016158221A1Sustained release formulation of naltrexoneOREXIGEN THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2661US2011028505A1Compositions and methods for reducing food cravingsOREXIGEN THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 2761US2013177602A1Layered pharmaceutical formulationsOREXIGEN THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 2861US2014364468A1Method for treating obesityOREXIGEN THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2959US2016193152A1Methods for administering weight loss medicationsOREXIGEN THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3058US2016338965A1Layered pharmaceutical formulationsOREXIGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3158US2015141452A1Compositions for affecting weight lossOREXIGEN THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3258US2017312269A1Compositions and methods for reducing food cravingsOREXIGEN THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3357US2017020990A1Compositions and methods for increasing insulin sensitivityOREXIGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3456US2010190793A1Compositions for affecting weight lossOREXIGEN THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 3556US2007148237A1Sustained-release formulation of zonisamideOREXIGEN THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3656US2007185084A1Compositions of an anticonvulsant and methods of using the same for reversing weight gainOREXIGEN THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 3756US2009018115A1Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight lossOREXIGEN THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3856US2008214592A1Methods of treating anxiety disordersOREXIGEN THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3955US2014080857A1Methods for prophylatic appetite suppressionOREXIGEN THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4052US2007179168A1Methods of treating anxiety disordersOREXIGEN THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4148US2016354348A1Methods for prophylatic appetite suppressionOREXIGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when OREXIGEN THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →